Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1)
Cited in blog · New England Journal of Medicine, 387(3), 205–216. · 2022
Jastreboff AM (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). *New England Journal of Medicine*, 387(3), 205–216.
Authors
Jastreboff AM
Research lens
Jastreboff AM (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). *New England Journal of Medicine*, 387(3), 205–216.
- blog
- glp1-protein-demand-circana-2026-09-04